The different NEG, NAT, and CRC target regions provided similar mutation profiles but showed their uniqueness in certain aspects, for example, in the case of the mutated genes and the number of mutations, suggesting the presence of some sort of heterogeneity. This evidence concerns the gene BRD2 and colorectal carcinoma.